Skip to Content
Coronavirus

AstraZeneca Covid-19 vaccine study paused after serious illness

covid-19 vaccine
MGN
By
Published 5:03 PM

NEW YORK, NY -- Late-stage studies of AstraZeneca's COVID-19 vaccine candidate are on temporary hold while the company investigates whether a patient had a serious side effect linked to the shot.

In a statement issued Tuesday evening, the company said it was pausing vaccinations to look into “a potentially unexplained illness," to see if the link is real or a coincidence.

Temporary halts in medical studies aren't uncommon.

Two other vaccines are in huge, final-stage tests in the United States. One is made by Moderna and the other by Pfizer and Germany’s BioNTech.

Article Topic Follows: Coronavirus

Jump to comments ↓

Associated Press

Related Articles

BE PART OF THE CONVERSATION

KVIA ABC 7 is committed to providing a forum for civil and constructive conversation.

Please keep your comments respectful and relevant. You can review our Community Guidelines by clicking here

If you would like to share a story idea, please submit it here.

Skip to content